Cargando…

Bioradiotherapy with Cetuximab May Reduce the Risk of Neck Node Relapse in Locoregionally Advanced Laryngeal Glottic Carcinoma: May HER1-Profile Be Useful in the Bioselection of Patients?

The aim of the study was to evaluate survival in patients with advanced glottic laryngeal squamous cell carcinoma treated by bioradiotherapy (BioRT) with cetuximab and eventual salvage surgery (group A, n = 66) or upfront surgery (total laryngectomy or near-total laryngectomy) with or without postop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almadori, Giovanni, Coli, Antonella, De Corso, Eugenio, Settimi, Stefano, Mele, Dario Antonio, Brigato, Francesca, Scannone, Domenico, Galli, Jacopo, Valentini, Vincenzo, Paludetti, Gaetano, Lauriola, Libero, Ranelletti, Franco Oreste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504760/ https://www.ncbi.nlm.nih.gov/pubmed/36143274 http://dx.doi.org/10.3390/jpm12091489

Ejemplares similares

Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival
por: Almadori, Giovanni, et al.
Publicado: (2022)

Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma
por: Almadori, Giovanni, et al.
Publicado: (2021)

When is a surgical multidisciplinary approach required in the management of head and neck non-melanoma skin cancer and in advanced head and neck pathologies involving skin?
por: Almadori, Giovanni, et al.
Publicado: (2021)

Bioselectivity Induced by Chirality of New Terpenyl Organoselenium Compounds
por: Obieziurska, Magdalena, et al.
Publicado: (2019)

Induction Chemotherapy Followed by either Chemoradiotherapy or Bioradiotherapy in Laryngeal Cancer
por: Larizadeh, Mohammad Hasan, et al.
Publicado: (2021)

Bioselectivity of silk protein-based materials and their bio-inspired applications
por: Bargel, Hendrik, et al.
Publicado: (2022)

Prognostic value of the maximum standardized uptake value for the locoregional control in early glottic cancer
por: Kim, Donghyun, et al.
Publicado: (2021)

Elective Neck Dissection during Salvage Total Laryngectomy: Personal Experience
por: Galli, Jacopo, et al.
Publicado: (2022)

Surface Plasmon Resonance Investigations of Bioselective Element Based on the Recombinant Protein A for Immunoglobulin Detection
por: Bakhmachuk, A., et al.
Publicado: (2017)

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy
por: Kuip, Evelien J. M., et al.
Publicado: (2018)

Unusual presentation of angiomyomatous hamartoma in an eight-month-old infant: case report and literature review
por: Catania, Vincenzo Davide, et al.
Publicado: (2012)

Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan
por: Kapała, Aleksandra, et al.
Publicado: (2021)

Facial pain: sinus or not?
por: DE CORSO, E., et al.
Publicado: (2018)

Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials
por: Gharzai, Laila A., et al.
Publicado: (2021)

The Same–Up–Down Staging System for Recurrent Early Glottic Cancer
por: Licci, Giuseppe, et al.
Publicado: (2023)

Glottic Spasm
Publicado: (1891)

A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Bi-Cheng, et al.
Publicado: (2019)

Clinical History, Prognostic Factors, and Management of Facial Nerve in Malignant Tumors of the Parotid Gland
por: Bussu, Francesco, et al.
Publicado: (2014)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

Role of Narrow Band Imaging Technology in the Diagnosis and Follow up of Laryngeal Lesions: Assessment of Diagnostic Accuracy and Reliability in a Large Patient Cohort
por: Galli, Jacopo, et al.
Publicado: (2021)

Real-Life Experience in the Management of Sinonasal Complications of Dental Disease or Treatments
por: De Corso, Eugenio, et al.
Publicado: (2022)

Bioselective PES Membranes Based on Chitosan Functionalization and Virus-Imprinted NanoMIPs for Highly Efficient Separation of Human Pathogenic Viruses from Water
por: Olivares Moreno, Carmen Andreina, et al.
Publicado: (2022)

Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study
por: Takeshita, Naohiro, et al.
Publicado: (2022)

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
por: Chen, Tien-Hua, et al.
Publicado: (2022)

Locoregional treatment of breast cancer during pregnancy
por: Toesca, Antonio, et al.
Publicado: (2014)

The Treatment of Glottic Spasm
Publicado: (1909)

Sub-Glottic Papillomata
por: Stockton, Frank O.
Publicado: (1888)

Glottic Kaposi's sarcoma
por: Xie, YongXiang, et al.
Publicado: (2023)

Prognostic Role of Serum Amino Acids in Head and Neck Cancer
por: Cadoni, Gabriella, et al.
Publicado: (2020)

Erratum to “Prognostic Role of Serum Amino Acids in Head and Neck Cancer”
por: Cadoni, Gabriella, et al.
Publicado: (2021)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

Glottic-SubGlottic adenoid cystic carcinoma. A case report and review of the literature
por: Testa, Domenico, et al.
Publicado: (2013)

Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer
por: NAKAMOTO, KENTARO, et al.
Publicado: (2013)

Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis
por: Wu, Li-Rong, et al.
Publicado: (2018)

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
por: Aggarwal, Himani, et al.
Publicado: (2020)

Long-term impact of smoking cessation on new glottic cancer events in patients with early glottic cancer
por: Kim, Min-Su, et al.
Publicado: (2022)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

Glottic Obstruction from Fibroepithelial Polyp
por: Jabbour, Joe, et al.
Publicado: (2019)

Surgical Management of Anterior Glottic Webs
por: Kuo, I-Chun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8d8s9nrvdgk9hatsndgmjuhgqp